5-Bromo-1-methyl-1H-benzo[d]imidazole

5-Bromo-1-methyl-1H-benzo[d]imidazole Suppliers list
Company Name: Shanghai Join Biological Pharmaceutical Co., Ltd.  Gold
Tel: 13818361018
Email: shzuolin@163.com
Company Name: Shanghai Thunder Biological Technology Co., Ltd.  Gold
Tel: 18621609968
Email: 1162686636@qq.com
Company Name: skychemical Co.Ltd  Gold
Tel: 021-20960837,QQ1332204249
Email: sales@skychemical.com
Company Name: Nordijia Biopharmaceutical (Suzhou) Co., Ltd.  Gold
Tel: 15150674956
Email: dannielee@nordicabio.com
Company Name: BeiJing Hwrk Chemicals Limted  
Tel: 0757-86329057 18934348241
Email: sales4.gd@hwrkchemical.com
5-Bromo-1-methyl-1H-benzo[d]imidazole Basic information
Product Name:5-Bromo-1-methyl-1H-benzo[d]imidazole
Synonyms:5-Bromo-1-methyl-1H-benzo[d]imidazole;5-BROMO-1-METHYL-1H-BENZIMIDAZOLE;5-Bromo-1-methylbenzimidazole;5-bromo-1-methyl-1H-1,3-benzodiazole;1H-Benzimidazole, 5-bromo-1-methyl-;5-Bromo-1-(methyl-d3)-1H-1,3-benzodiazole;1-Methyl-5-bromobenzimidazole
CAS:53484-15-4
MF:C8H7BrN2
MW:211.06
EINECS:
Product Categories:blocks;Bromides;Imidazoles
Mol File:53484-15-4.mol
5-Bromo-1-methyl-1H-benzo[d]imidazole Structure
5-Bromo-1-methyl-1H-benzo[d]imidazole Chemical Properties
Boiling point 317.2±34.0 °C(Predicted)
density 1.60
storage temp. Sealed in dry,Room Temperature
pka4.56±0.10(Predicted)
AppearanceLight brown to orange Solid
InChIInChI=1S/C8H7BrN2/c1-11-5-10-7-4-6(9)2-3-8(7)11/h2-5H,1H3
InChIKeyKMJMDIYGNFGEEO-UHFFFAOYSA-N
SMILESC1N(C)C2=CC=C(Br)C=C2N=1
Safety Information
MSDS Information
5-Bromo-1-methyl-1H-benzo[d]imidazole Usage And Synthesis
Synthesis
Triethyl orthoformate

122-51-0

4-broMo-N1-Methylbenzene-1,2-diaMine

69038-76-2

5-Bromo-1-methyl-1H-benzo[d]imidazole

53484-15-4

To a solution of triethyl orthoformate (10 mL) of 4-bromo-N'-methylbenzene-1,2-diamine (1.7 g, 8 mmol) was added p-toluenesulfonic acid monohydrate (PTSA-H2O, 152 mg, 0.8 mmol). The reaction mixture was stirred at 85 °C for 2 hours. After completion of the reaction, the mixture was poured into water (50 mL) and extracted with ethyl acetate (EA, 40 mL × 2). The organic layers were combined, dried with anhydrous sodium sulfate (Na2SO4), filtered and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate = 50/1 to 10/1) to afford 5-bromo-1-methyl-1H-benzo[d]imidazole (1.5 g, 89% yield) as a yellow solid.LC-MS m/z: 211.1 [M + H]+. Retention time (tR) = 1.90 min.

References[1] Patent: WO2017/176960, 2017, A1. Location in patent: Paragraph 00744
[2] Patent: WO2003/99776, 2003, A1. Location in patent: Page 34-35
Tag:5-Bromo-1-methyl-1H-benzo[d]imidazole(53484-15-4) Related Product Information
2-(5-Bromo-1H-benzo[d]imidazol-1-yl)ethanol 5-Bromo-1-(piperidin-4-yl)-1H-benzo[d]imidazole hydrochloride 5-Bromo-1-(4-methoxy-phenyl)-2-piperidin-2-yl-1H-benzoimidazole 5-Bromo-1-phenyl-1H-benzoimidazole 3-Bromo-2-methoxy-5-trifluoromethylpyridine AURORA KA-316 5-Bromo-1-methyl-1H-benzo[d]imidazole AURORA KA-315